We’ve just published a new article on the Bioentrepreneur site. (Here is the HTML version. To download the PDF, use the tool on the right hand side of page.) Written by Kleanthis Xanthopoulos and Garry Menzel, both at Regulus Therapeutics, the article examines why partnerships can sometimes fail and gives advice on how to keep them operating smoothly.
A problem, the authors write, is that some biotechs
“assume that the most important part of an alliance is the money. This could not be further from the truth. A good alliance is an investment in relationships”
The article also looks at academic partnering and includes data on select technology platform partnerships over recent years. It’s a useful piece, we think, and we’re happy to share it. Feel free to add your thoughts or criticisms in the comments section below.
Please sign in or register for FREE
If you are a registered user on Nature Portfolio Bioengineering Community, please sign in